Cellbion “Phase 2 clinical trial innovative anticancer drug,∙∙∙

Kim Kwon, CEO of Cellbion, “Effectiveness exceeds that of co∙∙∙

Cellbion’s challenge of ‘no failure three times’, showcasing∙∙∙

Cellbion, third challenge… Promotion of KOSDAQ listing∙∙∙

Cellbion challenges KOSDAQ listing for the 3rd time based on∙∙∙

Companies designated as excellent corporate research institu∙∙∙

The first radioactive drug...We're going to take the lead∙∙∙

'Development of Prostate Cancer Drugs' CellBion, passing the∙∙∙

"Looking for a wild cotyledon"...The K-blockbuster candidate∙∙∙

CellBion receives commendation from the Minister of Science ∙∙∙

CellBion, which develops prostate cancer treatment, seeks li∙∙∙

Bio venture CellBion seeks KOSDAQ listing∙∙∙

CellBion 'Treats Prostate 癌' CellBion to List on KOSDAQ Next∙∙∙

Kim Kwon, CEO of CellBion, said,∙∙∙

CellBion designates 'Lu-177-DGUL' innovative product as No. ∙∙∙

A terminal cancer patient held out, holding onto his grandch∙∙∙

CellBion, Canadian CPDC and Radioactive Prostate Cancer Trea∙∙∙

Selection of the 1st project for the CellBion National New D∙∙∙

Select 1000 National Representatives for CellBion Innovation∙∙∙

Prostate cancer treatment developer CellBion attracts KRW 10∙∙∙